Table 1.
Site characteristics for the participating boards and their provider networks
| N | % | ||
|---|---|---|---|
| Counties Represented (n=27) | |||
| County boards (n=18) | Title | Count | % |
| General Job Description (of interview participants) | Executive Director | 8 | 44.4 |
| Vice President/Director | 9 | 50.0 | |
| Medical Director | 1 | 5.6 | |
| People Served | <1000 | 4 | 22.2 |
| 1000–1999 | 6 | 33.3 | |
| 2000–3999 | 5 | 27.8 | |
| 4000+ | 3 | 16.7 | |
| Funds Used for Buprenorphine* | Medicaid | 18 | 100.0 |
| SAPT Block Grant | 7 | 38.9 | |
| Tax Levy | 13 | 72.2 | |
| State Grant | 1 | 5.6 | |
| Federal Grant | 3 | 16.7 | |
| Board provider network (n=36)* | |||
| Services** | Detoxification | 12 | 33.3 |
| Outpatient | 30 | 83.3 | |
| Intensive Outpatient | 26 | 72.2 | |
| Residential | 17 | 47.2 | |
| Physicians on Staff | Yes | 19 | 52.8 |
| No | 17 | 47.2 | |
| Use of Methadone On-Site | Yes | 5 | 13.9 |
| No | 31 | 86.1 | |
*
= This data does not represent interview data
**
= Multiple responses were possible.